ID: MRFR/HC/6894-HCR | February 2021 | Region: Global | 111 pages
Global Light Therapy Market is expected to cross USD 1,112.16 Million by 2025 at a CAGR of 5.1%.
Light therapy is also known as phototherapy or luminotherapy. The rising number of dermatological disorders cases and psychological conditions in developed as well as developing regions is fueling market growth. Increasing adoption of non-invasive methods and effectiveness of light therapy to treat skin cancer and other diseases are expected to boost overall demand for light therapy market during the forecast period.
Rising prevalence of SAD (seasonal affective disorder) and increasing reimbursement offered to patients for cancer, psoriasis, neonatal jaundice, and eczema by health insurance providers.
By Light Type
Frequently Asked Questions (FAQ) :
The global light therapy market is projected to reach a valuation of USD 1,112.16 MN by 2025.
The global light therapy market is projected to grow at approximately 5.1% CAGR during forecast period (2019-2025).
Rising cases of dermatological disorders and psychological conditions.
North America holds the largest share in the global Light therapy market, followed by Europe and the Asia Pacific, respectively.
Chal-Tec GmbH (Germany), Northern Light Technology (Canada), Beurer (Germany) BioPhotas (US), Verilux (US), Lucimed SA (Belgium), Koninklijke Philips (Netherlands), Zepter International (Switzerland), and Nature Bright (Taiwan), Lumie (UK), are some of the major players operating in the Light therapy market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.